Colwell Capital

Colwell Capital is a Calgary-based investor relations and capital markets advisory firm that specializes in the biotechnology, technology, and industrial sectors. The firm provides strategic communications, investor outreach, and capital raising support for both public and private companies, with a particular focus on the life sciences industry. Led by President Graeme Dick, Colwell Capital has over two decades of experience representing micro-cap and small-cap entities, including notable clients such as Bioasis Technologies and Kalytera Therapeutics. The firm works to introduce its clients to a broad network of retail and institutional investors, analysts, and social media platforms to enhance market visibility and shareholder value. By leveraging its deep expertise in capital markets, Colwell Capital assists emerging healthcare companies in navigating complex regulatory environments and securing the necessary funding for their development programs.